Hap Trading, LLC Marker Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$0.37 - $1.0 $4,181 - $11,300	-11,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.72 $2,755 - $4,988	-2,900 Reduced 20.42%	11,300 $0
Q3 2021 Nov 10, 2021	BUY	$1.68 - $2.88 $23,856 - $40,896	14,200 New	14,200 $1,000
Q3 2020 Nov 13, 2020	SELL	$1.5 - $2.2 $22,800 - $33,440	-15,200 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$1.69 - $2.79 $25,688 - $42,408	15,200 New	15,200 $4,000
Q1 2020 May 08, 2020	SELL	$1.59 - $3.35 $17,808 - $37,520	-11,200 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$2.68 - $4.85 $30,016 - $54,319	11,200 New	11,200 $6,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $255M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.